Core Scientific, Inc. Tranche 1 Warrants closed at $9.77 on Sep 28, down 8.05%, 56.5% below its 52-week closing high. Volume of 70.6K shares was 0.72× its 20-day average (below normal).
Split-adjusted performance: -10.6% over one month, +10.5% over six months, -6.5% over one year.
In the quarter ended Jun 30, 2026, revenue was $164.20M, up 108.8% from a year earlier, with a net margin of -658.4%.
Short interest was 993.9K shares at the Sep 15 settlement (12.1 days to cover).